Analysis and Control of Genotoxic Impurities in Drug Development
Wednesday, March 14th, 2012
01:30 - 03:30 PM Room: 311E
Jane Li and Shelly Li
We will be discussing the status and current advancement in the analysis and control of genotox impurities during drug development. Regulatory strategies in dealing with different categories and toxicities of specific impurities for various indications are also of relevance to the discussion. Attendees are envisioned to come together sharing knowledge and leave the network session with a better understanding of the “best practices” in working with genotoxic impurities.